[Indications for radioimmunotherapy for patients with non-Hodgkin's lymphoma]. / Indikationer for radioimmunterapi til patienter med non-Hodgkins lymfom.
Ugeskr Laeger
; 173(20): 1417-21, 2011 May 16.
Article
in Da
| MEDLINE
| ID: mdl-21586245
ABSTRACT
Radioimmunotherapy is a well-known treatment for non-Hodgkin's lymphoma. (90)yttrium (Y)-ibritumomab-tiuxetan consists of a radioisotope conjugated to a monoclonal anti-cluster of differentiation 20 antibody, which is targeted against B-lymphocytes. Initially the treatment indication was relapse of low-grade non-Hodgkin's lymphoma. However, (90)Y-ibritumomab-tiuxetan has later been used in clinical trials in the treatment of other types of non-Hodgkin's lymphoma and prior to stem cell transplantation. Based on the literature this systematic review aims to throw light on the future possibilities of radioimmunotherapy.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphoma, Non-Hodgkin
/
Radioimmunotherapy
Type of study:
Systematic_reviews
Limits:
Humans
Language:
Da
Journal:
Ugeskr Laeger
Year:
2011
Document type:
Article
Affiliation country:
Denmark